SynthesisAging2021

The efficacy and safety of PD-1/PD-L1 immune checkpoint inhibitors in treating advanced urothelial cancer: a meta-analysis of clinical trials.

Fei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.